 | West Nile Innovator | This vaccine is recommended for healthy horses as an aid in the prevention of disease caused by West Nile Virus. |
 | Prestige | For the immunization of horses against EHV respiratory infection (rhinopneumonitis). Rhinopneumonitis is caused by two equine herpesvirus: EHV1 and EHV4. Acute respiratory disease is characterized by fever (1040 to 1060), depression and a water discharge that gradually becomes thick with a yellow discharge. |
 | Prestige II | A combination of inactivated purified, concentrated, adjuvanted tissue culture origin equine herpesvirus EHV-1 and EHV-4 and equine influenza virus subtypes A1 and A2, including KY 93 strain. Bayer serological data suggest cross protection against certain U.S. and European strains including Prague 56, KY 63, KY 81 and 87, Fountainbleau 79 and Berlin 84 and 89. For vaccination of healthy horses against respiratory disease caused by equine herpesvirus and equine influenza virus. |
 | Prestige V | Prestige V is a highly efficacious 1 mL dose equine vaccine that provides broad protection against eastern and western encephalomyelitis, rhinopneumonitis respiratory (EHV-1 & EHV-4), equine influenza virus (A1 & A2), including new KY 93 strain and tetanus. |
 | Intervet Super-Tet | For the immunization of healthy horses and sheep against tetanus.
DOSAGE: For primary immunization, aseptically inject horses with 1 mL or sheep 0.5 mL intramuscularly and repeat the dose in three to four weeks. A 1 mL booster dose should be administered annually.
CAUTION: 21– day slaughter withdrawal. |
 | Prestige V+VEE | For vaccination of healthy horses against Eastern, Western and Venezuelan
Encephalomyelltis, Equine Influenza Virus and Tetanus, and as an aid in the prevention of respiratory disease caused by Equine Herpesvirus and Equine Influenza Virus. |
 | Tetanus Antitoxin | Recommended for use whenever a non-immunized animal, or one whose immune status is unknown, suffers a deep penetrating wound that has or may become contaminated with soil. It provides quick but short-term protection. Antitoxin may also be administered to animals following castration, docking and other operations performed on premises upon which tetanus infection has been a problem. DOSAGE: Administer 1,500 units subcutaneously or intramuscularly for passive immunity lasting about 7 to 14 days. |
 | Equiloid Innovator | This vaccine is recommended for use in healthy horses as an aid in the prevention of Eastern and Western equine encephalomyelitis and
tetanus. DOSAGE: Shake well. Administer one 1 mL dose intramuscularly. Inject a second 1 mL dose four to eight weeks after the first dose. Revaccinate annually with a single 1 mL dose. |
 | Pneumabort® K+1B | The only federally approved vaccine for use as an aid in the prevention of abortion due to EHV-1 infection in pregnant mares. The one rhinopneumonitis vaccine which contains both EHV-1 and EHV-1B. Killed vaccine.
DOSAGE: For Pregnant Mares: Administer one 2 mL dose intramuscularly during the 5th, 7th and 9th month of pregnancy. Revaccinate annually.For Young Horses: Inject one 2 mL dose intramuscularly followed by a second 2 mL dose three to four weeks later. Revaccinate six months after second primary dose and annually thereafter. Maiden and barren mares in contact with pregnant mares should be vaccinated on the same schedule as pregnant mares in which they are in contact with. |
 | PotomacGuard | This vaccine is recommended for use in healthy horses as an aid in the prevention of Potomac Horse Fever.
DOSAGE: Inject one 1 mL dose intramuscularly. Administer a second 1 mL dose three to four weeks after the first dose. Revaccinate annually with a single 1 mL dose. |
|